Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 25 Issue 10, October 2017

Letter

Top of page ⤴

Article

Top of page ⤴

Short Report

Top of page ⤴

Article Report

Top of page ⤴

Clinical Utility Gene Card

  • 1. Name of the disease (synonyms)

    Hereditary angioedema type III (HAE-III)

    Estrogen-related hereditary angioedema

    Hereditary angioedema with factor XII mutations (FXII-HAE)

    Hereditary angioedema of unknown origin (U-HAE)

    2. OMIM# of the disease

    610618

    3. Name of the analysed genes or DNA/chromosome segments:

    Coagulation factor XII; Hageman factor; F12; chromosome 5q.35.2-q35.3

    4. OMIM# of the gene(s)

    610619

    Review of the analytical and clinical validity as well as of the clinical utility of DNA-based testing for mutations in the F12 gene(s) in diagnostic, predictive and prenatal settings and for, risk assessment in relatives.

    • Christiane Stieber
    • Sven Cichon
    • Markus M Nöthen
    Clinical Utility Gene Card
Top of page ⤴

Search

Quick links